DK0623140T3 - Nye 19-nor steroider med en svovlcarbonkæde i 11-beta stilling, fremgangsmåde til deres fremstilling og mellemstofferne der - Google Patents
Nye 19-nor steroider med en svovlcarbonkæde i 11-beta stilling, fremgangsmåde til deres fremstilling og mellemstofferne derInfo
- Publication number
- DK0623140T3 DK0623140T3 DK93902339T DK93902339T DK0623140T3 DK 0623140 T3 DK0623140 T3 DK 0623140T3 DK 93902339 T DK93902339 T DK 93902339T DK 93902339 T DK93902339 T DK 93902339T DK 0623140 T3 DK0623140 T3 DK 0623140T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- preparation
- hydrogen
- intermediates
- steroids
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- GJEAMHAFPYZYDE-UHFFFAOYSA-N [C].[S] Chemical group [C].[S] GJEAMHAFPYZYDE-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 2
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- KCNKJCHARANTIP-SNAWJCMRSA-N allyl-{4-[3-(4-bromo-phenyl)-benzofuran-6-yloxy]-but-2-enyl}-methyl-amine Chemical compound C=1OC2=CC(OC/C=C/CN(CC=C)C)=CC=C2C=1C1=CC=C(Br)C=C1 KCNKJCHARANTIP-SNAWJCMRSA-N 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000732 arylene group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000005638 hydrazono group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000002923 oximes Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000002345 steroid group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9115856A FR2685332A1 (fr) | 1991-12-20 | 1991-12-20 | Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments. |
| PCT/FR1992/001193 WO1993013123A1 (fr) | 1991-12-20 | 1992-12-17 | Nouveaux 19-nor steroides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0623140T3 true DK0623140T3 (da) | 1999-02-15 |
Family
ID=9420274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93902339T DK0623140T3 (da) | 1991-12-20 | 1992-12-17 | Nye 19-nor steroider med en svovlcarbonkæde i 11-beta stilling, fremgangsmåde til deres fremstilling og mellemstofferne der |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6281204B1 (enExample) |
| EP (1) | EP0623140B1 (enExample) |
| JP (1) | JP3445271B2 (enExample) |
| KR (1) | KR100278465B1 (enExample) |
| CN (1) | CN1036718C (enExample) |
| AT (1) | ATE165365T1 (enExample) |
| AU (1) | AU666916B2 (enExample) |
| CA (1) | CA2124339C (enExample) |
| DE (1) | DE69225243T2 (enExample) |
| DK (1) | DK0623140T3 (enExample) |
| ES (1) | ES2115754T3 (enExample) |
| FI (1) | FI114866B (enExample) |
| FR (1) | FR2685332A1 (enExample) |
| HU (1) | HU221482B (enExample) |
| IL (1) | IL104105A (enExample) |
| MX (1) | MX9207421A (enExample) |
| NZ (1) | NZ246624A (enExample) |
| RU (1) | RU2111213C1 (enExample) |
| WO (1) | WO1993013123A1 (enExample) |
| ZA (1) | ZA929859B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2685332A1 (fr) * | 1991-12-20 | 1993-06-25 | Roussel Uclaf | Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments. |
| FR2706454B1 (fr) * | 1993-06-17 | 1995-09-15 | Roussel Uclaf | Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant. |
| DE19510862A1 (de) * | 1995-03-16 | 1996-09-19 | Schering Ag | Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle |
| DE19526146A1 (de) * | 1995-07-07 | 1997-01-09 | Schering Ag | Triphenylethylene, Verfahren zu deren Herstellung, diese Triphenylethylene enthaltene pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
| DE19724187A1 (de) * | 1997-06-02 | 1998-12-03 | Schering Ag | 11beta-Arylsubstituierte 14,17-Ethanoestratriene, Verfahren zur Herstellung dieser Verbindungen, sowie ihre Verwendung zur Herstellung von Arzneimitteln |
| HUP9802054A3 (en) * | 1997-10-14 | 2001-02-28 | Bayer Ag | Process for producing 4,4,5,5,5-pentafluor-1-pentanol |
| US6503896B1 (en) | 1997-12-24 | 2003-01-07 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| US6548491B2 (en) | 1997-12-24 | 2003-04-15 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| US6054446A (en) * | 1997-12-24 | 2000-04-25 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| DE19826213A1 (de) * | 1998-06-09 | 1999-12-16 | Schering Ag | Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| FR2780060B1 (fr) * | 1998-06-23 | 2000-08-04 | Hoechst Marion Roussel Inc | Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant |
| ATE222922T1 (de) * | 1998-11-20 | 2002-09-15 | Akzo Nobel Nv | Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11 |
| DE19929715A1 (de) * | 1999-06-24 | 2000-12-28 | Schering Ag | 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
| WO2001040805A1 (en) * | 1999-11-30 | 2001-06-07 | Akzo Nobel N.V. | Steroid compounds for steroid receptor binding assays |
| WO2005090379A1 (en) * | 2004-03-17 | 2005-09-29 | The Central Science Laboratory, 'csl' | Compounds and sensor for detecion of polycyclic aromatic hydrocarbons |
| EP1630167A1 (en) * | 2004-07-09 | 2006-03-01 | Proskelia SAS | Polymorphs of 19-Nor steroid derivatives |
| EP1623713A1 (en) * | 2004-07-09 | 2006-02-08 | Proskelia SAS | Cominations of pure anti-estrogen with aromatase inhibitors |
| CN100420681C (zh) * | 2005-04-29 | 2008-09-24 | 上海奥锐特国际贸易有限公司 | 多烯紫杉醇三水物的制备方法 |
| DE102008061722A1 (de) | 2008-12-12 | 2010-06-17 | Saltigo Gmbh | Verfahren zur Herstellung von Perfluoralkyl- oder Perfluoralkoxyalkanolen |
| DK3099306T3 (en) | 2014-01-29 | 2019-03-18 | Umecrine Cognition Ab | STEROID RELATIONSHIP TO USE IN THE TREATMENT OF HEPATIC ENCEPHALOPATHY |
| TWI748936B (zh) | 2015-01-12 | 2021-12-11 | 瑞典商優鎂奎認知Ａｂ公司 | 新穎化合物 |
| US10278977B2 (en) | 2016-06-06 | 2019-05-07 | Umecrine Cognition Ab | Methods for treating hypersomnolence |
| CN110117217B (zh) * | 2018-12-19 | 2021-09-28 | 浙江普洛家园药业有限公司 | 1-溴代甲基-2,3,5,6-四氟-4-(三氟甲基)苯的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2528434B1 (fr) * | 1982-06-11 | 1985-07-19 | Roussel Uclaf | Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament |
| FR2643638B1 (fr) * | 1989-02-24 | 1991-06-14 | Roussel Uclaf | Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
| DK0471612T3 (da) * | 1990-08-14 | 1999-02-22 | Hoechst Marion Roussel Inc | Nye 19-nor steroider med carbonkæde omfattende en amidgruppe i 11-beta-stillingen, fremgangsmåde til deres fremstilling, de |
| FR2685332A1 (fr) * | 1991-12-20 | 1993-06-25 | Roussel Uclaf | Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments. |
-
1991
- 1991-12-20 FR FR9115856A patent/FR2685332A1/fr active Granted
-
1992
- 1992-12-15 IL IL104105A patent/IL104105A/xx not_active IP Right Cessation
- 1992-12-17 AT AT93902339T patent/ATE165365T1/de not_active IP Right Cessation
- 1992-12-17 US US08/244,735 patent/US6281204B1/en not_active Expired - Fee Related
- 1992-12-17 DK DK93902339T patent/DK0623140T3/da active
- 1992-12-17 AU AU33570/93A patent/AU666916B2/en not_active Ceased
- 1992-12-17 JP JP51147893A patent/JP3445271B2/ja not_active Expired - Fee Related
- 1992-12-17 DE DE69225243T patent/DE69225243T2/de not_active Expired - Fee Related
- 1992-12-17 ES ES93902339T patent/ES2115754T3/es not_active Expired - Lifetime
- 1992-12-17 HU HU9402134A patent/HU221482B/hu not_active IP Right Cessation
- 1992-12-17 CA CA002124339A patent/CA2124339C/fr not_active Expired - Fee Related
- 1992-12-17 RU RU94031162/04A patent/RU2111213C1/ru not_active IP Right Cessation
- 1992-12-17 NZ NZ246624A patent/NZ246624A/en unknown
- 1992-12-17 WO PCT/FR1992/001193 patent/WO1993013123A1/fr not_active Ceased
- 1992-12-17 EP EP93902339A patent/EP0623140B1/fr not_active Expired - Lifetime
- 1992-12-17 KR KR1019940702134A patent/KR100278465B1/ko not_active Expired - Fee Related
- 1992-12-18 MX MX9207421A patent/MX9207421A/es not_active IP Right Cessation
- 1992-12-18 ZA ZA929859A patent/ZA929859B/xx unknown
- 1992-12-19 CN CN92115248A patent/CN1036718C/zh not_active Expired - Fee Related
-
1994
- 1994-06-17 FI FI942944A patent/FI114866B/fi not_active IP Right Cessation
-
2001
- 2001-06-26 US US09/891,433 patent/US6596885B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69225243D1 (de) | 1998-05-28 |
| FR2685332B1 (enExample) | 1995-06-02 |
| US6596885B2 (en) | 2003-07-22 |
| FI114866B (fi) | 2005-01-14 |
| NZ246624A (en) | 1995-12-21 |
| EP0623140A1 (fr) | 1994-11-09 |
| WO1993013123A1 (fr) | 1993-07-08 |
| CN1036718C (zh) | 1997-12-17 |
| RU2111213C1 (ru) | 1998-05-20 |
| US6281204B1 (en) | 2001-08-28 |
| IL104105A (en) | 1997-07-13 |
| HUT68068A (en) | 1995-05-29 |
| HU9402134D0 (en) | 1994-09-28 |
| AU3357093A (en) | 1993-07-28 |
| JPH07502281A (ja) | 1995-03-09 |
| EP0623140B1 (fr) | 1998-04-22 |
| FR2685332A1 (fr) | 1993-06-25 |
| ZA929859B (en) | 1993-12-20 |
| ES2115754T3 (es) | 1998-07-01 |
| AU666916B2 (en) | 1996-02-29 |
| FI942944L (fi) | 1994-06-17 |
| US20020072624A1 (en) | 2002-06-13 |
| CN1075722A (zh) | 1993-09-01 |
| JP3445271B2 (ja) | 2003-09-08 |
| FI942944A0 (fi) | 1994-06-17 |
| IL104105A0 (en) | 1993-05-13 |
| RU94031162A (ru) | 1996-04-20 |
| CA2124339A1 (fr) | 1993-07-08 |
| HU221482B (en) | 2002-10-28 |
| ATE165365T1 (de) | 1998-05-15 |
| CA2124339C (fr) | 2005-02-15 |
| MX9207421A (es) | 1993-07-01 |
| DE69225243T2 (de) | 1998-10-29 |
| KR100278465B1 (ko) | 2001-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0623140T3 (da) | Nye 19-nor steroider med en svovlcarbonkæde i 11-beta stilling, fremgangsmåde til deres fremstilling og mellemstofferne der | |
| ES8401498A1 (es) | Procedimiento de preparacion de nuevos derivados esteroides sustituidos en 11b. | |
| GB1266641A (enExample) | ||
| HU9401427D0 (en) | 19-nor steroide derivatives, process for producing them and compositions containing them | |
| SE8305422L (sv) | Foreningar med farmakologisk verkan, bland annat analgetisk verkan | |
| DE69023939D1 (de) | Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten. | |
| SE8105686L (sv) | Nya 17-oxazolin-steroidderivat, sett for framstellning derav och anvendning derav vid framstellning av kortikosteroider | |
| YU151390A (sh) | Novi estri organskih kiselina sa alkoholima izvedenim iz 19-nor steroida i njihovih soli, postupak za dobijanje istih kao i njihovih intermedijera, njihova primena u lekovima i preparati koji ih sadrže | |
| DK369780A (da) | 14-aminosteroider og syreadditionssalte deraf samt fremgangsmmaade til fremstilling deraf og 14-azidosteroider der er anvendelige som mellemprodukter ved fremgangsmaaden | |
| ES481314A1 (es) | Procedimiento para la preparacion de halogenobenzoin-o-metil-eter-oximas. | |
| ES472429A1 (es) | Un procedimiento para la preparacion de compuestos de 4-de-soxi-4-amino-eritromicina a. | |
| ATE9904T1 (de) | 2-thiazolyl-oxaminsaeurederivate, substituiert in position 4 durch ein thienyl- oder furylradikal, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| GB1471755A (en) | Derivatives of digoxin and digotoxin | |
| SE7714612L (sv) | Nya 11beta-substituerade steroidderivat och sett att framstella desamma | |
| ATE34740T1 (de) | (bis(hydroxymethyl)methyl)-isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten. | |
| ES439641A1 (es) | Procedimiento para la obtencion de 1, 3-dihidrogeno-hetero- ciclos. | |
| ES8400751A1 (es) | "procedimiento para preparar nuevos derivados organofosfonados". | |
| GB1120478A (en) | Improvements in or relating to steroids and the manufacture thereof | |
| IL74877A0 (en) | 9-halogen prostaglandin derivatives,process for the preparation thereof and pharmaceutical compositions containing the same | |
| JPS5649360A (en) | 2-oxoquinoline derivative | |
| GB1341768A (en) | Thiazole derivatives and theur use as plant growth control agents | |
| ES275437A1 (es) | Procedimiento para la preparaciën de nuevas aminas | |
| FR2303792A2 (fr) | 2-cyano-2-hydroxyiminoacetamides et acetates de ceux-ci en tant qu'agents de lutte contre les maladies de plantes | |
| ATE33983T1 (de) | N-substituierte tetrahydrothiazine, verfahren zu deren herstellung und deren verwendung als pestizide. | |
| ES287028A1 (es) | Procedimiento para la fabricacion de nuevos derivados basicos de fenoxazina y de sus sales |